Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
7.04 USD | -1.12% | -27.79% | -37.25% |
May. 15 | HC Wainwright Adjusts Fennec Pharmaceuticals Price Target to $15 From $18, Maintains Buy Rating | MT |
May. 14 | Transcript : Fennec Pharmaceuticals Inc., Q1 2024 Earnings Call, May 14, 2024 |
Financials (USD)
Sales 2024 * | 63.08M | Sales 2025 * | 66.72M | Capitalization | 192M |
---|---|---|---|---|---|
Net income 2024 * | 11M | Net income 2025 * | 16M | EV / Sales 2024 * | 3.05 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 2.88 x |
P/E ratio 2024 * |
17.1
x | P/E ratio 2025 * |
12
x | Employees | 29 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 83.94% |
Latest transcript on Fennec Pharmaceuticals Inc.
1 day | -1.12% | ||
1 week | -27.79% | ||
Current month | -23.31% | ||
1 month | -27.42% | ||
3 months | -21.86% | ||
6 months | -15.38% | ||
Current year | -37.25% |
Managers | Title | Age | Since |
---|---|---|---|
Rostislav Raykov
CEO | Chief Executive Officer | 48 | 09-07-06 |
Robert Andrade
DFI | Director of Finance/CFO | 49 | 09-07-06 |
Adrian Haigh
COO | Chief Operating Officer | 64 | 14-04-24 |
Members of the board | Title | Age | Since |
---|---|---|---|
Chris Rallis
BRD | Director/Board Member | 70 | 11-08-24 |
Khalid Islam
CHM | Chairman | 67 | 14-04-24 |
Robert Andrade
DFI | Director of Finance/CFO | 49 | 09-07-06 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.00% | 34 M€ | +3.87% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-17 | 7.04 | -1.12% | 306,769 |
24-05-16 | 7.12 | +2.01% | 361,909 |
24-05-15 | 6.98 | -4.90% | 780,522 |
24-05-14 | 7.34 | -26.75% | 1,105,061 |
24-05-13 | 10.02 | +2.77% | 127,534 |
Delayed Quote Nasdaq, May 17, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-37.25% | 192M | |
+9.42% | 115B | |
+11.84% | 106B | |
-1.05% | 21.96B | |
-14.15% | 21.84B | |
-5.29% | 19.21B | |
-4.16% | 18.08B | |
-38.29% | 17.71B | |
+7.99% | 14.32B | |
+36.24% | 12.42B |
- Stock Market
- Equities
- FENC Stock